Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2756)
All Articles published online
|
Jun 10, 2011 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hirsh V. Review of the treatment of metastatic non small cell lung carcinoma: A practical approach. World J Clin Oncol 2011; 2(6): 262-271 [PMID: 21773076 DOI: 10.5306/wjco.v2.i6.262] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v2/i6/262.htm |
| Number | Citing Articles |
| 1 |
Fady G Haddad, Hampig R Kourie, Joseph Kattan. Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives. Future Oncology 2017; 13(3): 201 doi: 10.2217/fon-2016-0325
|
| 2 |
Asmaa M. Zahran, Helal F. Hetta, Shimaa Mansour, Ereny S. Saad, Amal Rayan. Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study. Cancer Immunology, Immunotherapy 2021; 70(3): 733 doi: 10.1007/s00262-020-02704-7
|
| 3 |
Rui Han, Youhong Guan, Min Li, Aiqun Xu, Dong Wu, Pulin Li, Enze Wang, Peng Sun, Guanghe Fei, Sijing Zhou, Ran Wang, Yuan Seng Wu. Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-Analysis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9017198
|
| 4 |
Thomas Wibmer, Thierry Berghmans, Cornelia Kropf-Sanchen, Jean-Jacques Lafitte, Stefan Rüdiger, Marianne Paesmans, Ioanna Blanta, Arnaud Scherpereel, Kathrin M. Stoiber, Wolfgang Rottbauer, Jean-Paul Sculier, Christian Schumann. Histology as a Potential Clinical Predictor of Outcome in Advanced Non-Small-Cell Lung Cancer Treated with Vinorelbine and Mitomycin Combination Chemotherapy. Lung 2013; 191(3): 271 doi: 10.1007/s00408-013-9458-4
|
| 5 |
Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Ray D. Page, James Orsini, Hiroshi Sakai, Hui Zhang, Markus F. Renschler, Mark A. Socinski. Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 2014; 9(1): 83 doi: 10.1097/JTO.0000000000000011
|
| 6 |
LIHONG ZHANG, XUEJING YANG, ZHEN SUN, JIALI LI, HUI ZHU, JING LI, YAN PANG. Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer. Oncology Letters 2016; 11(4): 2605 doi: 10.3892/ol.2016.4273
|
| 7 |
Li Zhang, Yanyan Pan. Lung Cancer - Strategies for Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.78274
|
| 8 |
Yao-Kuang Wu, Chun-Yao Huang, Mei-Chen Yang, Chou-Chin Lan, Chih-Hsin Lee, Err-Cheng Chan, Kuei-Tien Chen. Nuclear survivin expression: a prognostic factor for the response to taxane–platinum chemotherapy in patients with advanced non-small cell lung cancer. Medical Oncology 2014; 31(8) doi: 10.1007/s12032-014-0079-4
|